Quick Summary:
As the global healthcare sector continues its rapid evolution, the demand and applicability of non-invasive prenatal testing (NIPT) has seen a significant rise. This expansive report on the global NIPT market presents a comprehensive overview of its trajectory of growth, leveraging data from 2018, with forecasts stretching till 2028.
The geographical segmentation covers key regions such as North America, South America, Asia & Pacific, Europe, and MEA, with in-depth analysis of notable countries in these regions. Beyond regional perspectives, the report also includes a detailed overview of the key global players in the NIPT market. The company profiles shed light on business information, SWOT Analysis, sales volume, revenue, price, gross margin and market share, fostering a broader perspective on the competitive landscape. This essential document is an indispensable tool for all forward-thinking executives aiming to stay ahead in the rapidly evolving NIPT space.
For the geography segment; regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Non-invasive Prenatal Test as well as some small players.
The information for each competitor includes:
- Company Profile
- Main Business Information
- SWOT Analysis
- Sales Volume, Revenue, Price and Gross Margin
- Market Share
Types Segment
- Test Device
- Consumable
Companies Covered
- Sequenom
- Illumina
- Ariosa
- Myriad Genetics
- Invitae Corp.
- Quest
- Premaitha Health PLC
- BGI
- Progenity
- Bio-Reference
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Sequenom
- Illumina
- Ariosa
- Myriad Genetics
- Invitae Corp.
- Quest
- Premaitha Health PLC
- BGI
- Progenity
- Bio-Reference
- Natera
Methodology
LOADING...